Daily Digest: Arm's IPO expected to be largest in years; AI drug biotech scores $200M
August 22, 2023 at 11:25 AM EDT
Meanwhile, Genesis Therapeutics, a Burlingame-based AI drug discovery company, raised $200 million in funding.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|